Our Story

HealthSpan Diagnostics began with an idea— improving patient care and outcomes by personalizing treatment options based on a patient’s molecular age. The company was founded on a technology from the laboratory of Dr Ned Sharpless, MD at University of North Carolina (currently Director of the National Cancer Institute). HealthSpan Dx is conducting rigourous clinical testing to bring the elegant idea of measuring physiologic reserve to physicians and patients for longer, healthier lives.